These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 5733721)
1. [The content of Vi-antibodies and 7S Vi-antibodies in the serum of typhoid patients treated with Vi-antigen and levomycetin]. Sukhoroslova LI; Andreeva NP Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):83-7. PubMed ID: 5733721 [No Abstract] [Full Text] [Related]
2. [Use of the hemagglutination test for detecting Vi-antibodies in the sera of patients with typhoid fever and chronic carrier state during treatment with levomycetin]. Anan'ina NA Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):146. PubMed ID: 6003869 [No Abstract] [Full Text] [Related]
3. [VI-antibody formation in typhoid patients treated with VI-antigen, pentoxyl and levomycetin]. Kuliev MM Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):55-9. PubMed ID: 5733863 [No Abstract] [Full Text] [Related]
4. [The dynamics of 0-antibodies of various physico-chemical properties in typhoid fever treated with levomycetin and VI-antigen]. Sukhoroslova LI Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):111-4. PubMed ID: 5731554 [No Abstract] [Full Text] [Related]
5. Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis. Chau PY; Tsang RS J Hyg (Lond); 1982 Oct; 89(2):261-7. PubMed ID: 7130702 [TBL] [Abstract][Full Text] [Related]
6. [Changes in serum bactericidal properties in patients with typhoid fever and chronic carrier state treated with levomycetin]. Anan'ina NA Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):98-101. PubMed ID: 4976155 [No Abstract] [Full Text] [Related]
7. [A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers]. Bunin KV; Firsanov VI; Kravtsov EG; Sukhoroslova LI; Kapuka LP Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):65-9. PubMed ID: 1007716 [TBL] [Abstract][Full Text] [Related]
8. [Immunologic shifts in typhoid patients following immuno-antibiotic therapy with levomycetin and VI-antigen according to the results of the passive VI-hemagglutination test]. Shneĭder VP Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):26-32. PubMed ID: 6004905 [No Abstract] [Full Text] [Related]
9. [Long-term observations for Vi-antibody formation in patients following typhoid fever, treated with Vi-antigen in combination with levomycetin]. Shneĭder VP Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):146. PubMed ID: 5615960 [No Abstract] [Full Text] [Related]
10. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine]. Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445 [No Abstract] [Full Text] [Related]
11. Influences of trimethoprim-sulphamethoxazole and chloramphenicol on immunoglobulin and antibody response in typhoid fever. Hsieh WC; Hsieh BS Southeast Asian J Trop Med Public Health; 1974 Mar; 5(1):17-21. PubMed ID: 4839076 [No Abstract] [Full Text] [Related]
12. [Treatment of typhoid fever patients with high doses of Vi-antigen in association with levomycetin]. Bunin KV; Sukhoroslova LI Sov Med; 1968 Sep; 31(9):17-22. PubMed ID: 5747026 [No Abstract] [Full Text] [Related]
13. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine]. Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572 [No Abstract] [Full Text] [Related]
14. [The dynamics of Vi-antibodies of different classes in typhoid patients during their treatment with levomycetin combined with alcoholic monovaccine and Vi-antigen]. Sukhoroslova LI; Deriagin IuP Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):15-8. PubMed ID: 4787689 [No Abstract] [Full Text] [Related]
15. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers]. Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200 [No Abstract] [Full Text] [Related]
16. [Recurrent typhoid in patients treated with levomycetin]. Shneĭder VP Klin Med (Mosk); 1966 Dec; 44(12):124-8. PubMed ID: 6004337 [No Abstract] [Full Text] [Related]
17. [Determination of 7S typhoid antibodies in the diagnosis of carrier state]. Liuksemburg KI; Chernokhvostova EV; Rozentalene LV; Beliaeva AI Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):18-23. PubMed ID: 6004903 [No Abstract] [Full Text] [Related]
18. [Clinical evaluation of the passive hemagglutination test in typhoid fever]. Kossakiewicz-Sulkońska B Przegl Epidemiol; 1970; 24(4):483-9. PubMed ID: 5495312 [No Abstract] [Full Text] [Related]
19. Differential agglutination of particulate Vi and O antigens by the IgM and IgG class antibodies. Chau PY; Ng MH Aust J Exp Biol Med Sci; 1978 Feb; 56(1):39-45. PubMed ID: 666676 [TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of diagnostic titers of incomplete O- and Vi-antibodies belonging to different immunoglobulin classes in typhoid fever and chronic bacterial carrier state]. Bunin KV; Suleĭmanov AK Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):96-7. PubMed ID: 494903 [No Abstract] [Full Text] [Related] [Next] [New Search]